Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 40 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  2. US 9402820

    Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  3. US 9402889

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  4. US 9399672

    Hepatitis C virus neutralizing antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  5. US 9394358

    Gene signature for predicting prognosis of patients with solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  6. US 9394364

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  7. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  8. US 9394352

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  9. US 9388222

    Modified Pseudomonas exotoxin A

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 12, 2016 · Expires Jul 7, 2036

    granted

  10. US 9382311

    HIV-1 broadly neutralizing antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  11. US 9370559

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Heath Services · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  12. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  13. US 9364557

    Fold-back diabody diphtheria toxin immunotoxin and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  14. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  15. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  16. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  17. US 9352032

    Live attenuated antigenically marked classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted May 31, 2016 · Expires May 26, 2036

    granted

  18. US 9353353

    Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted

  19. US 9345748

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  20. US 9346859

    Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted

  21. US 9341619

    Hyposialylation disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2016 · Expires May 12, 2036

    granted

  22. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted

  23. US 9333251

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted

  24. US 9326992

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.